Literature DB >> 7498298

Effect of diterpenoid alkaloids on cardiac sympathetic efferent and vagal afferent nerve activity.

H Chiao1, S W Pelletier, H K Desai, W R Rebagay, R W Caldwell.   

Abstract

The diterpenoid alkaloid, lappaconitine, at a dose of 150 micrograms/kg (i.v.) increased cardiac vagal afferent nerve activity (16.2%) and reduced cardiac sympathetic efferent nerve activity (12.5%). A polar analog, N-deacetyllappaconitine, at this same dose, increased cardiac vagal afferent nerve activity (40%) and reduced cardiac sympathetic efferent nerve activity (23.5%). Both of these agents also reduced arterial blood pressure and heart rate. A larger dose of lappaconitine (300 micrograms/kg i.v.) produced the same changes in nerve activities and cardiac function as the lower dose. Two other structurally related agents, lycoctonine and aconine, failed to alter these variables in doses up to 300 micrograms/kg. These data suggest that certain diterpenoid alkaloids activate autonomic reflex receptors, including cardiac reflex receptors. The polar agent, N-deacetyllappaconitine, appears to be more effective on cardiac reflex receptors than the non-polar agent, lappaconitine. Such agents may be useful in the treatment of hypertension.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7498298     DOI: 10.1016/0014-2999(95)00290-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

1.  Aconitine facilitates spontaneous transmitter release at rat ventromedial hypothalamic neurons.

Authors:  Hisashi Yamanaka; Atsushi Doi; Hitoshi Ishibashi; Norio Akaike
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

2.  A model study toward the total synthesis of N-deacetyllappaconitine.

Authors:  Douglass F Taber; Jiang-Lin Liang; Bei Chen; Lisi Cai
Journal:  J Org Chem       Date:  2005-10-28       Impact factor: 4.354

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.